	US 11,793,767 B2
	Geranium oil and constituents thereof for treatment of neurodegenerative diseases
Anat Elmann, Rehovot (IL); and Uzi Ravid, Haifa (IL)
Assigned to THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT AGRICULTURE RESEARCH ORGANIZATION, Rishon Lezion (IL)
Filed by The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization, Rishon Lezion (IL)
Filed on Feb. 20, 2020, as Appl. No. 16/795,709.
Application 16/795,709 is a continuation of application No. 14/399,178, abandoned, previously published as PCT/IB2013/053657, filed on May 7, 2013.
Claims priority of provisional application 61/688,050, filed on May 7, 2012.
Prior Publication US 2020/0188320 A1, Jun. 18, 2020
Int. Cl. A61K 36/185 (2006.01); A23L 27/12 (2016.01); A23L 33/105 (2016.01); A61K 31/045 (2006.01); A61K 31/122 (2006.01); A23L 33/115 (2016.01)

CPC A61K 31/045 (2013.01) [A23L 27/12 (2016.08); A23L 33/105 (2016.08); A23L 33/115 (2016.08); A61K 31/122 (2013.01); A61K 36/185 (2013.01); A23V 2002/00 (2013.01)]

5 Claims

1. A method for treating a neurodegenerative condition, comprising administering to a subject in need thereof a composition comprising, as the sole active ingredient, geranium oil extracted from Pelargonium graveolens in an amount effective for the treatment of the neurodegenerative condition, wherein said neurodegenerative condition is selected from the group consisting of Alzheimer's disease, Parkinson's disease, Parkinsonian dementia (PDem), Parkinson's disease dementia (PDD), dementia with Lewy bodies (DLB), anorexia nervosa, traumatic brain injury (TBI), and Parkinson's disease falling short of dementia (CIND-PD).